Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.96 AUD | -0.14% | +2.65% | -9.38% |
Mar. 25 | Miners, healthcare firms push Australia stocks higher | RE |
Mar. 19 | Australia shares flat ahead of key RBA policy decision | RE |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- With a P/E ratio at 10.57 for the current year and 9.59 for next year, earnings multiples are highly attractive compared with competitors.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- For the past twelve months, EPS forecast has been revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.38% | 4.92B | A+ | ||
-15.55% | 9.31B | A- | ||
-6.22% | 6.32B | C | ||
-12.33% | 4.72B | B- | ||
+8.52% | 4B | B | ||
-6.16% | 3.94B | - | ||
-20.76% | 3.71B | A- | ||
-5.50% | 3.6B | B | ||
+19.66% | 3.5B | B+ | ||
0.00% | 3.12B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DXS Stock
- Ratings DEXUS